Oligomerization of recombinant and endogenously expressed human histamine H4 receptors

被引:50
作者
van Rijn, Richard M.
Chazot, Paul L.
Shenton, Fiona C.
Sansuk, Kamonchanok
Bakker, Remko A.
Leurs, Rob
机构
[1] Vrije Univ Amsterdam, Leiden Amsterdam Ctr Drug Res, Dept Med Chem, NL-1081 HV Amsterdam, Netherlands
[2] Univ Durham, Sch Biol & Biomed Sci, Durham, England
关键词
D O I
10.1124/mol.105.020818
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, we report the homo- and hetero-oligomerization of the human histamine H4R by both biochemical (Western blot and immobilized metal affinity chromatography) and biophysical [bioluminescence resonance energy transfer and time-resolved fluorescence resonance energy transfer (tr-FRET)] techniques. The H4R receptor is the most recently discovered member of the histamine family of G-protein-coupled receptors. Using specific polyclonal antibodies raised against the C-terminal tail of the H4R, we demonstrate the presence of H4R oligomers in human embryonic kidney 293 and COS-7 cells heterologously overexpressing H(4)Rs and putative native H4R oligomers in human phytohaemagglutinin blasts endogenously expressing H(4)Rs. Moreover, we show that H4R homo-oligomers are formed constitutively, are formed at low receptor densities (300 fmol/mg of protein), and are present at the cell surface, as detected by tr-FRET. The formation of these oligomers is independent of N-glycosylation and is not modulated by H4R ligands, covering the full spectrum of agonists, neutral antagonists, and inverse agonists. Although we show H4R homo-oligomer formation at physiological expression levels, the detection of H1R-H4R hetero-oligomers was achieved only at higher H1R expression levels and are most likely not physiologically relevant.
引用
收藏
页码:604 / 615
页数:12
相关论文
共 55 条
[1]   Detection of β2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET) [J].
Angers, S ;
Salahpour, A ;
Joly, E ;
Hilairet, S ;
Chelsky, D ;
Dennis, M ;
Bouvier, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3684-3689
[2]   Dimerization: An emerging concept for G protein-coupled receptor ontogeny and function [J].
Angers, S ;
Salahpour, A ;
Bouvier, M .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 :409-435
[3]   Discovery of naturally occurring splice variants of the rat histamine H3 receptor that act as dominant-negative isoforms [J].
Bakker, RA ;
Lozada, AF ;
van Marle, A ;
Shenton, FC ;
Drutel, G ;
Karlstedt, K ;
Hoffmann, M ;
Lintunen, M ;
Yamamoto, Y ;
van Rijn, RM ;
Chazot, PL ;
Panula, P ;
Leurs, R .
MOLECULAR PHARMACOLOGY, 2006, 69 (04) :1194-1206
[4]   Domain swapping in the human histamine H1 receptor [J].
Bakker, RA ;
Dees, G ;
Carrillo, JJ ;
Booth, RG ;
López-Gimenez, JF ;
Milligan, G ;
Strange, PG ;
Leurs, R .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (01) :131-138
[5]   Histamine H1-receptor activation of nuclear factor-κB:: Roles for Gβγ- and Gαq/11-subunits in constitutive and agonist-mediated signaling [J].
Bakker, RA ;
Schoonus, SBJ ;
Smit, MJ ;
Timmerman, H ;
Leurs, R .
MOLECULAR PHARMACOLOGY, 2001, 60 (05) :1133-1142
[6]   Structure-based analysis of GPCR function:: Evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein [J].
Banères, JL ;
Parello, J .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 329 (04) :815-829
[7]   The use of resonance energy transfer in high-throughput screening: BRET versus FRET [J].
Boute, N ;
Jockers, R ;
Issad, T .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (08) :351-354
[8]   Oligomerization of G-protein-coupled transmitter receptors [J].
Bouvier, M .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (04) :274-286
[9]   Probing the differential effects of infrared light sources IR1072 and IR880 on human lymphocytes: Evidence of selective cytoprotection by IR1072 [J].
Bradford, A ;
Barlow, A ;
Chazot, PL .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2005, 81 (01) :9-14
[10]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3